Literature DB >> 2838253

In vivo distribution of parathyroid hormone receptors in bone: evidence that a predominant osseous target cell is not the mature osteoblast.

M F Rouleau1, J Mitchell, D Goltzman.   

Abstract

Previous studies in vitro and in vivo have demonstrated the presence of receptor sites for PTH on cells of the osteoblast phenotype. Nevertheless, it is unclear whether the diverse functions of this hormone in bone can all be attributed to its interaction with a single cell type. In this study, we have used a radioautographic method to examine the competitive binding of 125I-labeled rat PTH-(1-34) to the long bones of rats in vivo. Our studies confirm the presence of competitive binding to mature osteoblasts and the absence of significant competitive binding to multinucleated osteoclasts. However, by light and electron microscopic radioautographic analysis, the majority of specific competitive PTH binding was present over a cell in the intertrabecular space of the metaphyseal region, which was distinct from the mature osteoblast. This large mononuclear cell with multiple cytoplasmic extensions appeared to interface with both the bone matrix and the microvascular osseous circulation and may provide an additional target to mediate hormonal effects on the skeleton.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838253     DOI: 10.1210/endo-123-1-187

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Expression of the parathyroid hormone receptor and correlation with other osteoblastic parameters in fetal rat osteoblasts.

Authors:  M P Bos; J M van der Meer; J H Feyen; M P Herrmann-Erlee
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

2.  Confocal images of marrow stromal (Westen-Bainton) cells.

Authors:  P Bianco; A Boyde
Journal:  Histochemistry       Date:  1993-08

3.  Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters.

Authors:  K A McCuaig; H S Lee; J C Clarke; H Assar; J Horsford; J H White
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

4.  Endosteal surfaces in hyperparathyroidism: an enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies.

Authors:  P Bianco; E Bonucci
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage.

Authors:  N Amizuka; M Y Kwan; D Goltzman; H Ozawa; J H White
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Expression of mRNA of parathyroid hormone-related peptide in fetal bones of the rat.

Authors:  R Karmali; S N Schiffmann; J M Vanderwinden; G N Hendy; N Nys-DeWolf; J Corvilain; P Bergmann; J J Vanderhaeghen
Journal:  Cell Tissue Res       Date:  1992-12       Impact factor: 5.249

7.  Elevation of alkaline phosphatase activity induced by parathyroid hormone in osteoblast-like cells from the spinal hyperostotic mouse TWY (twy/twy).

Authors:  A Terakado; M Tagawa; S Goto; M Yamazaki; H Moriya; S Fujimura
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

8.  PTH prevents the adverse effects of focal radiation on bone architecture in young rats.

Authors:  Abhishek Chandra; Shenghui Lan; Ji Zhu; Tiao Lin; Xianrong Zhang; Valerie A Siclari; Allison R Altman; Keith A Cengel; X Sherry Liu; Ling Qin
Journal:  Bone       Date:  2013-03-05       Impact factor: 4.398

9.  Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.

Authors:  K Dickson; A Philip; H Warshawsky; M O'Connor-McCourt; J J Bergeron
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes.

Authors:  Stefano Zanotti; Ernesto Canalis
Journal:  Bone       Date:  2017-07-01       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.